Received Feb 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | N3HL7 | — |
Pharmacist called on 24-Feb-2026 to report the accidental administration of SHINGRIX to a 17-year-old patient; Pharmacist called on 24-Feb-2026 to report the accidental administration of SHINGRIX to a 17-year-old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 17-year-old male patient who received Herpes zoster (Shingrix) (batch number N3HL7, expiry date 17-JUN-2027) for prophylaxis. Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis. On 24-FEB-2026, the patient received Shingrix. On an unknown date, the patient did not receive Flu vaccine. On 24-FEB-2026, an unknown time after receiving Shingrix the patient experienced inappropriate age at vaccine administration (Verbatim: Pharmacist called on 24-Feb-2026 to report the accidental administration of SHINGRIX to a 17-year-old patient) and wrong vaccine administered (Verbatim: Pharmacist called on 24-Feb-2026 to report the accidental administration of SHINGRIX to a 17-year-old patient). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. Additional Information: GSK receipt date 24-FEB-2026 The pharmacist reported the accidental administration of Shingrix. The patient was supposed to receive instead was the flu vaccine. The pharmacist mentioned that the patient was not immunocompromised and wanted to know which side effects they could expect for the patient. No further details provided. The reporter consented to follow up.